Common TitleMK-0639
Official Title A Multiclinic, Open Study to Evaluate the Ability of the Combination of Indinavir, Zidovudine and Lamivudine to Result in Sustained Suppression of HIV-1 in Asymptomatic HIV-1 Seropositive Patients
Phase Phase IV
ClinicalTrials.gov NCT00002179
Treatments
Indinavir
Indinavir
Tradename:CrixivanOther Names:IDVClass:Protease Inhibitors (PI)Funding
IndustryMerck Sharp & Dohme Corp